Skip to main content

Table 3 Before and after VD supplementation anthropometric and laboratory data of the supplemented patients (obese/non-obese) (results presented as mean ± SD)

From: Lipid profile of childhood cancer survivors and the effects of vitamin D supplementation: a prospective study

 

Obese patients

Non-obese patients

Before VD supplementation (N = 17)

After VD supplementation (N = 15)

Before VD supplementation (N = 20)

After VD supplementation (N = 20)

BMI

29.4 ± 3.27

27.35 ± 1.5

18.2 ± 1.1

18.6 ± 2.4

BMI-Z score

2.24 ± 0.42

2.11 ± 0.22

0.42 ± 0.74

0.43 ± 0.62

Calcium (mg/dl)

9.9 ± 0.5

9.6 ± 0.5

9.7 ± 0.5

9.6 ± 0.3

Phosphorus (mg/dl)

5.2 ± 1.3

5.4 ± 0.5

5.4 ± 0.1

5.3 ± 0.4

Magnesium (mg/dl)

2.31 ± 0.25

2.32 ± 0.35

2.32 ± 0.31

2.38 ± 0.22

PTH (pg/ml)

44.7 ± 10.7

43.2 ± 9.9

44.2 ± 8.9

34.3 ± 14.2** (P = 0.0119)

25OH-VD (ng/ml)

13.30 ± 5.67

18.73 ± 6.61* (P = 0.018)

15.36 ± 5.73

26.74 ± 4.48** (P < 0.0001)

TC (mg/dl)

182.6 ± 22.3

162.3 ± 21.1* (P = 0.013)

172.4 ± 20.2

161.4 ± 24.2

TG (mg/dl)

88.7 ± 45.2

86.6 ± 34.1

86.0 ± 25.7

83.0 ± 29.3

HDL-C (mg/dl)

42.5 ± 12.6

43.4 ± 10.7

44.5 ± 17.2

42.5 ± 11.3

LDL-C (mg/dl)

109.8 ± 26.8

94.8 ± 20.6* (P = 0.049)

92.3 ± 21.7

90.5 ± 25.3

  1. BMI body mass index, PTH parathyroid hormone, 25OH-VD 25-hydroxyvitamin D, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol
  2. *P ≤ 0.05 of significance (obese before and after VD supplementation)
  3. **P ≤ 0.05 of significance (obese after VD supplementation versus non-obese patients after VD supplementation)